PA-27-101: NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
PA-27-101 is a National Institutes of Health notice on Grants.gov (posted) whose eligibility includes small businesses. Posted May 28, 2026; close date Apr 5, 2029. The eligibility text below is quoted from the notice; read the official notice before applying. Real federal grants never charge an application fee.
Eligibility
Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Applicant types listed by Grants.gov: Small businesses
Agency, posted date, and close date
| Opportunity number | PA-27-101 |
|---|---|
| Agency | National Institutes of Health |
| Status on Grants.gov | posted |
| Posted | 2026-05-28 |
| Close date | 2029-04-05 |
| Notice type | synopsis |
| Funding instrument | Grant |
| Category of funding activity | Health |
| Cost sharing or matching required | Yes |
| Assistance listing (CFDA) | 93.853, 93.838, 93.839, 93.866, 93.307, 93.847 |
Official Grants.gov notice
Open the official notice on Grants.gov ↗
Source: Grants.gov (search2 / fetchOpportunity API) (as of 2026-05-28). Figures can change; check the source.
Related notices
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-RM-27-016 · closes Nov 23, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-10-09
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-RM-27-025 · closes Nov 23, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-10-09
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-RM-27-007 · closes Nov 23, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-10-09
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Department of Health and Human Services
National Institutes of Health · PA-23-317 · closes Nov 24, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2023-11-24
Microplastics Research and Resource Coordination Center (U24 - Clinical Trial Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-ES-27-003 · closes Dec 1, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-06-29
National Center for Construction Safety and Health Research and Translation (U54)
Department of Health and Human Services
Centers for Disease Control and Prevention - ERA · RFA-OH-24-001 · closes Dec 1, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2023-09-13
Something wrong or outdated? Send a correction.